Marley Brimberry is a registered patent agent with a Ph.D. in Biochemistry and Molecular Biology and more than a decade of research experience spanning enzymology, protein engineering, molecular biology, and structural biology. She leverages her extensive laboratory and analytical training to help clients secure and strategically manage intellectual property in biotechnology, pharmaceuticals, chemistry, and related life sciences technologies.
Before entering patent practice, Marley completed her Ph. D. at the University of Georgia, where her research focused on structure–function relationships in heme-dependent enzymes and radical SAM methyltransferases involved in anaerobic heme degradation. Her work integrated protein biochemistry, steady-state and transient-state kinetics, spectroscopy, and structural analysis to elucidate electron transfer pathways in pathogenic systems.
She subsequently conducted postdoctoral research at the University of Michigan in the Department of Chemistry, where she bioengineered Chlorophyll(ide) a Oxygenase as an enzymatic tool for chlorophyll biosynthesis. Her work combined bioinformatics, rational mutagenesis, fluorescence-based protein folding assays, and structure-guided enzyme engineering to interrogate and optimize catalytic function.
Her technical expertise includes enzymology, protein expression and purification (including metalloproteins, membrane proteins, and oxygen-sensitive proteins), kinetic analysis, molecular cloning, bioinformatics, structure-based mutagenesis, and protein X-ray crystallography.
Marley drafts and prosecutes U. S. and international patent applications across a range of complex technologies, including biologics, enzyme engineering, small molecules, and medical devices.
Credentials
Education
- Indiana University, B.S., biochemistry, 2014
- University of Georgia, Ph.D., biochemistry and molecular biology, 2022